Instagram · May 16, 2026
FoodPharmer Backs Doctor Sued Over 'Fake ORS' Claims Amidst Ongoing Legal Battles
Bad news. Dr. Shivranjani ko ek court case mil gaya. Inhone fake ORS ke khilaf awaz uthaya tha aur ab us company ne inke upar case dal diya. Main Dr. Shivranjani ko strongly support karta hu because I have faced this way too much. Mujhe 9 court cases, 2 crore defamation suit aur 6 month imprisonment charge ka dhamki bhi mila hai. Mera in companies se ek hi sawal hai ki aapke paas mehenge lawyers, Bollywood celebrities aur cricketers ke liye paisa hai to good quality ingredients ke liye paisa kyu nahi hai? Jo paisa aap lawyers aur marketing mein kharcha karte ho, agar aap woh ingredients mein kharcha kar lete to shayad humein aap pe video banane ka zaroorat hi nahi padta. Mujhe poori koshish karna hai ki jo main face kiya hu woh aur kisi ke saath na ho. Main Dr. Shivranjani ko strongly support karta hu because I believe that this isn't just a court case, this is an attack on freedom of speech. And freedom of speech includes the freedom to criticize. So let's keep criticizing wherever necessary and let's make India healthy again. Share this video to support Dr. Shivaranjani.
What's right
What's wrong
What's debatable
Breakdown
The central claims regarding Dr. Shivranjani's legal troubles for her advocacy against misleading ORS products are accurate and well-supported by multiple reliable news sources from around the upload date (March 29, 2026) and remain accurate as of today (May 16, 2026).
Her eight-year campaign led to a significant FSSAI ban on non-compliant ORS labeling in October 2025, although a court stay allowed some companies to sell existing stock. The speaker, Revant Himatsingka (Foodpharmer), also has a well-documented history of facing legal challenges and receiving multiple legal notices from food companies for his consumer advocacy, supporting his claim of having faced similar issues.
However, the precise numbers of "9 court cases, 2 crore defamation suit, and 6 month imprisonment charge" as actual legal actions against the speaker are not explicitly confirmed in the search results, although the threat of such actions is plausible in the context of his legal battles. The assertion that companies "do not have money for good quality ingredients" is a simplification; the issue is more accurately described as some companies choosing to use formulations that did not meet WHO ORS standards, prioritizing commercial interests and marketing over medically appropriate ingredient profiles.
The visual text aligns with the audio, providing no conflicting information. [1][2][3]